Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Current Taxes: 2019-2024

Historic Current Taxes for Ptc Therapeutics (PTCT) over the last 5 years, with Dec 2024 value amounting to $4.7 million.

  • Ptc Therapeutics' Current Taxes fell 51.31% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 51.31%. This contributed to the annual value of $4.7 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Ptc Therapeutics' Current Taxes is $4.7 million, which was down 0.23% from $4.7 million recorded in FY2022.
  • Over the past 5 years, Ptc Therapeutics' Current Taxes peaked at $4.7 million during FY2022, and registered a low of $1.3 million during FY2021.
  • Its 2-year average for Current Taxes is $4.7 million, with a median of $4.7 million in 2022.
  • Its Current Taxes has fluctuated over the past 5 years, first skyrocketed by 764.73% in 2020, then crashed by 70.17% in 2021.
  • Yearly analysis of 4 years shows Ptc Therapeutics' Current Taxes stood at $4.3 million in 2020, then crashed by 70.17% to $1.3 million in 2021, then spiked by 266.12% to $4.7 million in 2022, then reached $4.7 million in 2024.